Previous 10 | Next 10 |
INVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration Joins INVO Bioscience to accelerate INVOcell's global OB/GYN clinical integration strategy PR Newswire SARASOTA, Fla. , July 14, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NA...
Through its wholly-owned subsidiary, INVO Centers, INVO Bioscience ([[INVO]] +6.4%) to open an INVO clinic in Atlanta with a joint venture agreement in partnership with reproductive specialist Dr. Sue Ellen Carpenter, M.D.The clinic, Bloom Fertility, is scheduled to o...
INVO Bioscience Signs Joint Venture Agreement with Bloom Fertility to Open an INVOcell Fertility Clinic in Atlanta INVO Bioscience and established reproductive specialist Dr. Sue Ellen Carpenter, MD of Bloom Fertility today announce their partnership to make INVOcell, an innovat...
INVO Bioscience (INVO) announces the appointment of Andrea Goren as the company's chief financial officer.In a career approaching 27 years, Goren has extensive experience in numerous financial functions, including service as a public company CFO, company director, capital ...
INVO Bioscience Appoints Andrea Goren as Chief Financial Officer PR Newswire SARASOTA, Fla. , June 15, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture...
INVO Bioscience, Inc. (INVO) Q1 2021 Earnings Conference Call May 17, 2021 16:30 ET Company Participants Joe Diaz - Investor Relations Steve Shum - Chief Executive Officer Conference Call Participants Scott Henry - ROTH Capital Kyle Bauser - Colliers Securities John Heerdink - Vista Partners ...
INVO BioScience (INVO): Q1 GAAP EPS of -$0.25 misses by $0.08.Revenue of $0.68M (+161.5% Y/Y) beats by $0.09M.Shares +2.5%.Press Release For further details see: INVO BioScience EPS misses by $0.08, beats on revenue
INVO Bioscience Reports First Quarter 2021 Financial and Operating Results and Provides Business Update Company to Host Conference Call Today at 4:30pm ET (Details Below) PR Newswire SARASOTA, Fla. , May 17, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq:...
INVO Bioscience to Report First Quarter 2021 Financial Results on Monday, May 17, 2021 Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET PR Newswire SARASOTA, Fla. , May 11, 2021 /PRNewswire/ -- INVO Bioscien...
INVO Bioscience Appoints Meryle Lynn Chamberlain to Lead Marketing for Global Brand Expansion Aggressive go-to-market sales, partnerships, and marketing strategy to bring INVOcell, fertility care that is accessible, inclusive, and affordable to the more than 90% of couples in ne...
News, Short Squeeze, Breakout and More Instantly...
SARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the establishment and acquisition of fertility clinics, and with the intrava...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...
2024-04-18 06:37:00 ET Here’s the Top 3 Reasons to Trade Penny Stocks in 2024 Penny stocks represent a unique investment opportunity for those looking to diversify their portfolios with high-growth potential securities. Characterized by their low price per share, typically under ...